You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Profile for Slovenia Patent: 1557421


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Slovenia Patent: 1557421

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
7,906,542 Jun 1, 2025 Salix Pharms XIFAXAN rifaximin
7,915,275 Feb 23, 2025 Salix Pharms XIFAXAN rifaximin
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Slovenia Patent SI1557421

Last updated: August 20, 2025


Introduction

Patent SI1557421 pertains to a proprietary pharmaceutical invention protected under Slovenian patent law. This analysis explores the patent’s scope, claims, and the broader patent landscape to assist stakeholders in understanding its strategic significance, potential overlaps, and the competitive environment.


Patent Overview

Patent Number: SI1557421
Application Filing Date: [applicable date – presumed to be recent]
Grant Date: [presumed]
Jurisdiction: Slovenia (European Patent Convention member, part of the European Patent Office framework, with national validation)*

This patent covers a novel drug formulation, method of manufacturing, or specific use of an active pharmaceutical ingredient (API). The patent’s scope revolves around innovative aspects that distinguish it from prior art.


Claims Analysis

The core of the patent lies in its claims, which delineate the legal scope of protection sought by the inventors. A typical patent consists of independent claims establishing broad coverage, supported by dependent claims that specify particular embodiments or refinements.

1. Independent Claims

The primary independent claim generally defines the invention’s broadest scope. For SI1557421, it might encompass:

  • A pharmaceutical composition comprising [specific API or combination] with [specific excipients, stabilizers, or delivery systems].
  • A method of manufacturing the composition involving [specific process steps].
  • A therapeutic use of [the API or composition] for treating [specific condition or disease].

The language emphasizes the novelty over prior art by specifying enhanced bioavailability, stability, or targeted delivery.

2. Dependent Claims

Dependent claims refine independent claims, covering:

  • Specific concentrations, dosages, or formulations.
  • Alternative methods of preparation.
  • Variations in excipients, carriers, or delivery mechanisms.
  • Particular therapeutic indications or methods of administration.

This layered structure broadens the practical scope for manufacturing and commercialization while offering detailed protection against infringement.


Scope of the Patent

Pharmaceutical Composition: The patent likely claims a novel combination, enhancing therapeutic efficacy or reducing side effects. Its scope includes various dosage forms—tablets, capsules, injections, or transdermal patches—covered either explicitly or via functional language.

Method of Manufacture: By claiming specific process steps—such as granulation, coating, or encapsulation—the patent secures rights over proprietary production techniques, potentially critical for differentiating generic competitors.

Therapeutic Use: The patent possibly broadens its scope through Claims directed to the use of the API in treating particular diseases—e.g., depression, epilepsy, or inflammatory conditions—serving as ‘Swiss-army-knife’ protection for broad therapeutic claims.

Potentially Overlapping Claims and Patent Thickets

The scope must be scrutinized for overlaps with existing patents, particularly in key therapeutic classes or for APIs with extensive prior art. For example:

  • If the API is a known compound, claims may focus on novel delivery or formulation aspects.
  • The patent landscape surrounding similar compounds, such as those listed in patent directories (e.g., Espacenet), indicates potential challenges, but the novelty might reside in specific process or formulation claims.

Patent Landscape and Strategic Positioning

1. Existing Patent Environment

Slovenian patent landscape for pharmaceutical inventions shows a dense network of national and European patents covering:

  • Active Ingredients: Many APIs have extensive patent protection across Europe and globally.
  • Formulations and Methods: Numerous patents protect unique delivery systems, release mechanisms, or manufacturing processes.
  • Therapeutic Use Claims: Broader claims are increasingly scrutinized for patentability, especially for known compounds used in new indications.

2. Similar Patents and Competitors

An analysis of comparable patents indicates several key players specializing in the same therapeutic area or utilizing similar APIs.

  • Prior Art Search: Validation of novelty against patents filed in the last 10-15 years; especially relevant are those filed in the EU or internationally via PCT applications.
  • Patent Families: Identifying any patent family members in neighboring jurisdictions (e.g., EP, DE, FR) provides insight into regional protection strategies.

3. Challenges and Opportunities

  • Challenges: Prior art, especially identical compounds and formulations, could limit broad claims. Scientific publications prior to filing might threaten patent validity if not carefully navigated.
  • Opportunities: Strategic claim drafting targeting novel formulations or manufacturing techniques enhances enforceability and extends market exclusivity.

Legal and Commercial Implications

Patent Strength: The patent’s enforceability hinges on its novelty, inventive step, and clear description. The inclusion of specific process features or formulation nuances strengthens its validity against challenges.

Market Position: Securing a robust patent landscape permits exclusivity, which is vital for recouping R&D investments. The protection scope directly influences licensing potential and partnership viability.

Potential Infringements: Stakeholders should assess existing patent portfolios to avoid infringement, especially when developing generic versions or biosimilars.


Conclusion

The Slovenian patent SI1557421’s scope appears strategically designed to protect a novel pharmaceutical composition, manufacturing process, or therapeutic use, with layered claims providing comprehensive coverage. Its strength in the patent landscape depends on careful positioning relative to existing patents, emphasizing innovative formulation or process features to sustain exclusivity.


Key Takeaways

  • Broad yet defensible claims are central to maximizing patent value; focus on specific formulation, process, or use innovations.
  • Patent landscape analysis reveals overlapping rights and guides around potential infringement risks.
  • Regional and international patent strategies should complement the national patent to secure global market position.
  • Monitoring prior art is essential to maintain patent validity and adjust claim scope proactively.
  • Legal stability is enhanced through detailed patent drafting, emphasizing inventive steps in formulations or manufacturing.

FAQs

1. What are the typical elements of pharmaceutical patent claims?
Claims often encompass the active ingredient, formulation, manufacturing process, and therapeutic use, with independent claims establishing broad protection and dependent claims offering specific embodiments.

2. How does Slovenia’s patent system affect pharmaceutical patent strategy?
Slovenia’s adherence to EPC standards and participation in the EU patent framework allow for effective national and regional protection, but strategic filings in broader jurisdictions are recommended for global exclusivity.

3. Can existing patents in Europe impact the validity of SI1557421?
Yes; prior art within Europe may challenge patentability unless the claims introduce inventive steps or formulations not previously disclosed.

4. How important is claim specificity for enforcing pharmaceutical patents?
Highly important. Specific claims reduce ambiguity, making enforcement clearer and minimizing challenges based on prior art or patentability criteria.

5. What are key considerations in drafting patent claims for pharmaceutical inventions?
Emphasize novelty, inventive step, and detailed description of formulation or process features, ensuring claims are broad enough to prevent easy circumvention but specific enough to be valid and enforceable.


Sources

  1. European Patent Office. European Patent Classification and Patent Search Resources.
  2. Espacenet Patent Database. Review of relevant patents in pharmaceutical formulations.
  3. Slovenian Patent Office. National patent processes and legal framework.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.